# Investment Analysis: Waterdrop Inc. (WDH)

**Date:** September 24, 2025
**Author:** Gemini AI

## 1. Executive Summary

Waterdrop Inc. (WDH) presents a compelling, albeit speculative, investment case. After a period of significant losses, the company has demonstrated a strong and consistent turnaround to profitability over the last three years. Its recent earnings growth and positive cash flow recovery outpace several of its insurtech peers like Root, SelectQuote, and Clover Health, who exhibit more erratic or negative performance.

Given its current low market price (around $1.90), WDH could be undervalued if it sustains its current growth trajectory. The primary risks are the historical volatility of its financials and the intense competition within the Chinese insurance marketplace. However, compared to its peers, WDH appears to be on a more stable and promising path.

## 2. Introduction

Waterdrop Inc. is a technology platform dedicated to insurance and healthcare service in China. It operates a model that connects users with insurance underwriters, offering a wide range of online insurance products. This analysis evaluates its investment potential by examining its net cash flow and earning power over the past five years and comparing it against key competitors.

## 3. Financial Analysis of Waterdrop Inc. (WDH)

**Current Market Price (as of analysis date):** ~$1.90 USD

### Earning Power (EBIT)

*   **2020:** -$92.41 M
*   **2021:** -$280.00 M
*   **2022:** +$93.53 M
*   **2023:** +$23.32 M
*   **2024:** +$50.07 M
*   **2025 (TTM):** +$53.93 M

**Analysis:** WDH experienced substantial losses in 2020 and 2021. However, the company executed a remarkable turnaround, achieving significant profitability in 2022 and maintaining solid, growing earnings since. This trend indicates a successful strategic shift and stabilization of its business model.

### Net Cash Flow (Net Change in Cash)

*   **2020:** +$4.48 M
*   **2021:** +$25.43 M
*   **2022:** +$87.88 M
*   **2023:** -$157.40 M
*   **2024:** +$73.01 M

**Analysis:** Cash flow has been more volatile. While strong in 2022, it saw a significant dip in 2023 despite positive earnings, which could be a concern related to working capital or investment activities. However, the strong rebound in 2024 is a positive sign that the company is managing its cash effectively again.

## 4. Peer Comparison

To contextualize WDH's performance, we compare it with three other publicly traded insurtech companies.

| Company | Metric | 2021 | 2022 | 2023 | 2024 |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Waterdrop (WDH)** | **Net Income** | **-$280 M** | **+$94 M** | **+$23 M** | **+$50 M** |
| | **Net Cash Flow** | **+$25 M** | **+$88 M** | **-$157 M**| **+$73 M** |
| **Root (ROOT)** | Net Income | -$521 M | -$298 M | -$147 M | +$30 M |
| | Net Cash Flow | -$407 M | +$56 M | -$83 M | -$79 M |
| **SelectQuote (SLQT)**| Net Income | +$125 M | -$298 M | -$59 M | -$34 M |
| | Net Cash Flow | -$115 M | -$338 M | -$19 M | +$15 M |
| **Clover Health (CLOV)**| Pretax Income | -$760 M | -$440 M | -$280 M | -$59 M |
| | Free Cash Flow | N/A | N/A | N/A | +$33 M |

**Analysis:**
*   **WDH** stands out for its consistent profitability in the last three years, whereas its peers have largely struggled with sustained losses.
*   **Root Inc. (ROOT)** only recently achieved profitability in 2024 and still maintains negative cash flow.
*   **SelectQuote (SLQT)** has been unprofitable for three straight years, with erratic cash flow.
*   **Clover Health (CLOV)** has consistently posted large losses, making WDH's performance appear far superior.

## 5. Investment Potential & Conclusion

Waterdrop Inc.'s ability to pivot from heavy losses to sustained profitability is a strong bullish signal. Its earning power appears more robust and reliable than its peers. While the 2023 cash flow dip warrants caution, the 2024 recovery mitigates this concern.

Given that WDH is outperforming its peers on the bottom line and is trading at a low stock price, it holds significant potential for appreciation if it can maintain its growth and profitability. It represents a stronger investment candidate within the speculative insurtech sector compared to the peers analyzed.

---
***Disclaimer:** This analysis is based on publicly available financial data and is for informational purposes only. It does not constitute financial advice. All investment decisions should be made with the consultation of a qualified financial professional.*
